COLORADO SPRINGS, Colo., July 10, 2025 — Colorado ONE Fund, the venture capital arm of ONE Funds dedicated to accelerating critical technologies, is proud to announce its latest investment in CisLunar Industries, a pioneering company transforming in-space advanced power processing and resource utilization for the next era of space exploration and national security.

CisLunar Industries is at the forefront of developing critical power infrastructure for space and making their products adaptable to leverage mass manufacturing on Earth. Nearly everything in space runs on electricity, but power processing is a supply bottleneck, a common source of mission failure, and a limiting factor on spacecraft mission capability. With scalable and differentiated hardware and software for power and material processing, CisLunar Industries cuts customer wait times and non-recurring engineering costs, increases resiliency and efficiency, and leaves more room on the spacecraft for expanded mission capability.

CisLunar Industries’ Electronic Power Intelligent Conversion (EPIC) technologies process power to drive many aspects of a space industrial economy. For in-space mobility, the company leads the development of power processing units (PPUs) for high power electric propulsion and nuclear electric propulsion systems. For dual use beaming for Golden Dome and industrial applications, such as laser, x-ray, electron, and neutral particle, they have pioneered and flown products that successfully generated one of the highest voltages ever produced in space. For in-space manufacturing and resource utilization, the company not only converts power but also processes materials using their modular Space Foundry™ and Lunar Wire Extruder, state-of-the-art technologies at the center of the value chain that connects resources with markets.

“CisLunar Industries is addressing one of the most pressing challenges and opportunities in the emerging cislunar economy,” said Kevin O’Neil, CEO of ONE Funds. “Their innovative approach to in-space power infrastructure and resource utilization not only reduces the costs and risks associated with space missions but also strengthens U.S. leadership in space sustainability and security. We are excited to support their vision of a thriving economy in space, where energy and matter are harnessed and shaped to build a free and resilient future.”  

Headquartered in Loveland, Colorado, CisLunar Industries is leveraging technical excellence and scalable manufacturing on Earth to achieve the benefits it delivers to customers. The investment from Colorado ONE Fund will accelerate the company’s technology development, expand its engineering team, and support key demonstration missions with government and commercial partners.

“Partnering with Colorado ONE Fund is a major milestone for CisLunar Industries,” said Gary Calnan, CEO and Co-Founder of CisLunar Industries. “Their commitment to impact-driven investment and their deep expertise in aerospace and defense make them the ideal partner as we scale our operations and bring our breakthrough technology to market. Together, we are building the infrastructure that will power the next generation of space exploration and economic growth.”

About CisLunar Industries
CisLunar Industries designs and builds scalable advanced products for power conversion and material processing, enabling in-space mobility, national security, and manufacturing for government and commercial customers.

For more information, visit: www.cislunarindustries.com.
Follow us on: Facebook | LinkedIn | Twitter

About ONE Funds
Founded in 2023, ONE Funds focuses on impact investing in the defense sector. With a unique ecosystem, ONE Funds connects defense technology innovators with government leadership, applying a strategic consortium model to grow small businesses. Boasting 250 years of cumulative defense experience, ONE Funds invests in aerospace and national defense technologies to deliver strong returns while advancing critical security innovations. As part of ONE Funds, Colorado ONE Fund partners with the Colorado Venture Capital Authority (VCA) to back early-stage, high-impact technologies supporting national defense. Learn more at www.onefunds.com.

Media contacts:

CisLunar Industries:
Ubaldo Ciminieri
[email protected]
303.725.9417

ONE Funds:
German Nunez
Managing Director
[email protected] 

SOURCE ONE Funds

MIAMI, July 10, 2025 — Lorient Capital, an investment firm focused exclusively on healthcare, today announced the final close of Lorient Healthcare Fund III, with $500 million in total commitments. The fund, which closed on June 30^th, was oversubscribed, surpassing its original $350 million target.

Lorient partners with founder-led healthcare companies in the middle market, bringing sector expertise, hands-on operational capabilities, and a repeatable approach to scaling mission-driven businesses. The firm has built a track record of supporting improvements in clinical outcomes, workforce efficiency, and access to care across the U.S. healthcare system.

“Fund III represents a major step forward in our mission to support companies working to improve the healthcare system and create long-term, sustainable value,” said David Berman and Jordan Broome, Co-Managing Partners at Lorient Capital. “We’re deeply grateful to our existing partners for their continued support and to our new investors who share our conviction that healthcare investing can drive both strong returns and meaningful impact.”

A Disciplined Strategy in Healthcare

Lorient targets control-oriented investments in healthcare providers, services, and technology companies. The firm focuses on sectors experiencing transformation and growth, such as consumer-directed healthcare, post-acute care, behavioral health, provider enablement, and tech-enabled services, where its operational model can help drive performance.

Lorient-backed companies aim to advance quality of care, expand access in underserved and rural markets, address workforce shortages, integrate care for vulnerable populations, and support the transition to value-based models. One of Lorient’s five core operational domains is quality, which is actively managed and measured in partnership with clinical leaders using the firm’s proprietary tools and operating approach.

Since inception, Lorient has completed 20 platform investments and over 75 add-on acquisitions. The firm’s nine realized exits reflect a consistent ability to build, scale, and create value across its portfolio.

Morpheus: Lorient’s Operational Advantage

At the center of Lorient’s model is Morpheus, the firm’s proprietary technology platform. Morpheus consolidates fragmented clinical, operational, and financial data into real-time, actionable insights that support growth and performance.

“Morpheus is our engine for accelerating transformation,” said Jordan Broome. “It enables us to go beyond capital, embedding the tools, insights, and capabilities our portfolio companies need to scale effectively and deliver better care.”

More than a reporting system, Morpheus integrates directly into a company’s workflows and infrastructure, benchmarking performance, identifying operational gaps, and supporting leadership teams. This drives faster decision-making, higher-quality care, and closer alignment between day-to-day operations and long-term strategy.

Looking Ahead

With Fund III, Lorient will continue to support high-quality management teams in scaling healthcare businesses that blend operational rigor with clinical focus. The close of Fund III reinforces Lorient’s position as a strategic partner to founders and investors and provides added momentum to execute on its disciplined, operations-led investment strategy.

SOURCE Lorient Capital

1Pitch™ Persuasion System Officially Launches After Helping Startup Founders Generate Millions in Under 100 Days

SINGAPORE, July 10, 2025 — After watching his family lose everything to a financial scam and spending years trying to rebuild from scratch, Jason Lim turned his painful past into purpose. Today, he announces the official launch of 1Pitch™ Persuasion System, a step-by-step method designed to help founders close high-stake deals, raise capital, and hit revenue targets faster than ever.

The launch follows a successful beta phase where a select group of entrepreneurs used the system to generate exponential results—often in less than 100 days. Among them:

• A father of five turned a $2,000 website pitch into a $2 million opportunity
• A second-generation laundry business owner added $3 million in ARR
• A wellness founder recruited 34 distributors in 29 days
• A fund manager secured $29,693 in his first 16 days and opened a new 8-figure greenfield market

The 1Pitch system stands out by doing what most programs don’t: simplifying communication at the root level. Instead of overwhelming users with complexity, the system teaches a neuroscience-backed, 5-step framework designed to create instant rapport, shift buyer psychology, and command attention in high-pressure boardrooms.

But for Jason, 1Pitch is more than just a business—it’s redemption.

“I didn’t build this to get rich. I built it because I failed. I let my family down. I yelled at my brother when I should’ve been there for him. No success is worth that. I made a vow: if I could rise again, I’d teach others how to win without losing everything that matters,” says Jason Lim, founder of 1Pitch.

Jason began teaching as a basketball coach at age 16, and later went on to close over $7 million in deals by the age of 24. But after falling victim to investment fraud and losing it all, he spent years couch-surfing and rebuilding not just his finances—but his identity. It was during that period that he discovered his obsession with teaching and the deep impact of mentorship done right.

The result is 1Pitch—a “copy-paste” persuasion blueprint that compresses over 20 years of real-world experience into a fast-track system that can be completed in under 20 hours. Graduates have called it “the F1 of persuasion”—not just for closing deals, but for influencing decisions, building trust quickly, and standing out as a category of one in any industry.

Program Highlights:

• Learn to predict buying behavior using neuromarketing and decision science
• Follow a repeatable 5-step system to close UHNWI clients and raise capital
• Build instant trust with stakeholders in any pitch, presentation, or negotiation
• Shrink sales cycles and eliminate time-wasting objections
• Use behavioral science to move conversations from “maybe” to “yes” with ease

Unlike most programs that rely on charisma or talent, 1Pitch is designed for anyone—regardless of background—to learn and deploy. It offers founders a proven path to close powerfully, fast, and with integrity.

For Jason, the ultimate goal is simple: to help others win without regret.

“No amount of money can buy back lost time with family. This system is my way of giving others the chance to build wealth without losing what truly matters.”

About 1Pitch™ Persuasion System
1Pitch is a neuroscience-based persuasion framework built for founders, dealmakers, and leaders who want to close more effectively. It was created by Jason Lim, Singapore’s top pitch mentor, after decades of experience in sales, negotiation, and behavioral psychology. The system is now available to the public for the first time.

Enrollment is now open at AuthorJason.com/1pitch.

Media Contact:
Jason Lim
[email protected]
+65 8973 9139
1Pitch™ Persuasion System, Singapore

SOURCE Jason Lim

Cloud Storage Management Platform Simplifies Storage Optimization, Cutting Costs by 50%

NEW YORK, July 10, 2025 — Autonomous storage optimization startup Datafy has secured new funding, bringing total investment to $20 million. The round was led by Bessemer Venture Partners, with participation from existing investor Insight Partners, with the primary goal of accelerating the company’s growth in the U.S.

With cloud storage costs soaring, Datafy’s rapid customer adoption highlights an urgent demand for cloud storage efficiency. “At Via, efficiency and stability aren’t just internal goals; they’re promises we make to cities and passengers every day. That means our infrastructure has to be just as dependable,” said Lior Gernenstein, CTO, Via. “Datafy has the system to automatically scale storage as demands shift, without downtime or wasted spend. With clear visibility into utilization, we can make smarter infrastructure decisions and stay focused on delivering reliable, resilient transportation to the communities we serve.”

H2O.ai, the world’s leading agentic AI company, serves industry giants such as AT&T, Workday, and many more. The company has seen immediate results. “With Datafy, we reduced EBS costs by 40% where possible, while maintaining the flexibility to automatically scale cloud storage as needed. The performance improvements were immediate, and the solution’s simplicity and reliability truly stood out”, said Ophir Zahavi, Senior Manager, Cloud Engineering, H2O.ai.

Datafy’s approach is practical and non-disruptive; instead of relying on recommendations, its solution is 100% autonomous, reducing the burden on users to perpetually right-size their storage demands. This empowers FinOps and DevOps teams to reduce costs while maintaining complete control over their storage operations.

The Datafy solution includes a zero-downtime auto-scaling engine, paired with a free sensor that monitors storage usage in real-time, requiring no code changes or engineering lift.

The new investment accelerates Datafy’s expansion, including growing its U.S. presence and introducing new storage optimization solutions. Its partner program is also gaining traction, with several AWS Premier Partners already part of Datafy’s ecosystem.

“Storage demands are at an all-time high, and businesses need efficiency without complexity,” said Zivan Ori, CEO of Datafy. “This latest funding validates the strong customer traction we’ve seen and allows us to scale quickly to meet growing demand.”

“Unlike so many others trying to help customers save cloud costs on the operational level, Datafy has taken a deep tech approach and developed a product for the most demanding and sophisticated users of cloud storage,” concluded Adam Fisher, Bessemer Venture Partners. 

Founded by industry veterans CEO Zivan Ori, COO Ziv Serlin, and CPO Yoav Ilovich – former storage leaders with decades of expertise – Datafy is redefining how enterprises manage cloud storage. Ori and Serlin previously co-founded E8 Storage, which AWS acquired in 2019.

For more information, visit www.datafy.io

About Datafy

Datafy is setting a new standard in cloud storage management with its pioneering technology and expert leadership team, including industry veterans Zivan Ori, Yoav Ilovich, and  Ziv Serlin. The company’s mission is to help enterprises control cloud storage costs, offering a solution that promises up to 50% savings on storage expenses. With Datafy, businesses can achieve self-optimizing, developer-independent cloud storage management.

Media Contact

Emily Gallagher
PRSENSE
[email protected]

Logo – https://mma.prnewswire.com/media/2727919/Datafy_Logo.jpg

SOURCE Datafy

Booz Allen and Corsha join forces to secure the machine identity layer – a rapidly growing and underserved market – for mission-critical operational systems

WASHINGTON, July 10, 2025 — Corsha, the first and only Machine Identity Provider (mIDP) purpose-built to secure machine-to-machine (M2M) communication across operational systems and critical infrastructure, today announced a strategic investment from Booz Allen Ventures, the corporate venture capital arm of Booz Allen Hamilton. The investment will accelerate Corsha’s mission to deliver secure machine identity and access management (IAM) for operational environments powering advanced manufacturing and industrial systems, national defense, and critical infrastructure.

The investment by Booz Allen underscores the urgent need for strong authentication and dynamic machine identity as federal agencies and enterprises race to implement Zero Trust architectures across increasingly autonomous, interconnected systems. Corsha’s patented machine identity platform (mIDP) ensures that every automated connection is fully verified and authorized at machine speed and scale.

“Our world is shifting rapidly toward autonomy, automation, and connected machines. That future demands a new kind of identity infrastructure, purpose-built for mission systems and critical infrastructure,” said Anusha Iyer, CEO and Founder of Corsha. “Booz Allen brings unmatched scale, mission expertise, and deep roots in national security. We’re thrilled to partner with them to expand the impact of our machine identity platform and secure the operational systems that power the world.”

As an advanced technology company and the leading provider of AI and cybersecurity to the federal government, Booz Allen is building solutions in agentic AI, autonomous mission systems, and Zero Trust. Corsha delivers a critical building block as the first identity provider purpose-built for machines at a time when machines outnumber humans 80:1. This investment builds on Corsha’s momentum of its $18 million Series A-1 round, which includes investments from Sinewave, Razor’s Edge Ventures, and Ten Eleven Ventures.

“Corsha stands out for its technical depth, mission focus, and elegant solution to a growing problem in operational cybersecurity,” said Chris Woods, Investor at Booz Allen Ventures. “Corsha’s broad application in the non-human identity space excites us, beginning with their approach to securing machine identities aligns perfectly with the Department of Defense’s strategic priorities around Zero Trust, autonomy, and resilience. We believe Corsha is uniquely positioned to become foundational infrastructure for next-generation mission systems.”

As federal agencies race to meet Zero Trust mandated deadlines, they need fine-grained access control not just for users, but also for the machines that power modern defense and industrial systems. Corsha’s mIDP platform delivers:

• Strong, cryptographic machine identities for every system
• Dynamic authentication and access at every connection
• Automated lifecycle management for millions of machine identities
• Secure deployments in diverse environments from cloud to air-gapped, hybrid, and industrial

“Identity is the new perimeter, and that starts with machines,” said David Forbes, Director of Cyber-Physical Defense at Booz Allen and leader of the firm’s Zero Trust for operational technology efforts. “As operational environments become more dynamic and more connected, Corsha’s platform delivers the kind of adaptive, identity-first machine security that Zero Trust requires. Booz Allen sees tremendous potential to operationalize this approach across mission-critical domains to help safeguard the nation.”

This investment from Booz Allen supports a new phase of growth for Corsha as it works to embed trusted machine identity into the fabric of modern infrastructure and automated systems, from manufacturing and energy to space, defense, and critical infrastructure.

To learn more about Corsha’s platform and mission, visit corsha.com.

About Corsha
Corsha is the first and only machine identity platform purpose-built to secure operational systems and critical infrastructure. Corsha’s patented Machine Identity Provider (m-IdP) allows enterprises to securely connect systems, move data, and automate with confidence from anywhere to anywhere. Corsha is backed by leading venture capital firms including SineWave, Razor’s Edge, Ten Eleven Ventures, and Booz Allen Ventures.

SOURCE Corsha

VAUGHAN, ON, July 9, 2025 – Minus Waste Solutions, a leading provider of sustainable food waste recycling and resource recovery services, is pleased to announce it has secured a significant growth equity investment from the Canada Business Growth Fund (CBGF).

This strategic partnership will support Minus Waste Solutions’ mission to transform food waste into valuable resources while expanding its footprint across Canada and beyond. The investment will accelerate the company’s plans to scale operations, enhance its technology platforms, and pursue strategic acquisitions in the waste management sector.

“We are thrilled to partner with CBGF as we take Minus Waste Solutions into its next phase of growth,” said Leonidas Anagnostakos, President of Minus Waste Solutions. “This investment further validates our business model and our team’s dedication to providing innovative, sustainable solutions for food waste diversion. Together with CBGF, we are well positioned to drive meaningful impact in advancing a circular economy.”

CBGF invests in ambitious Canadian companies with proven track records and strong growth potential. “Minus Waste Solutions has built a highly differentiated and scalable platform in the waste management industry,” said Dale Tingley, Co-Managing Partner at Canada Business Growth Fund. “We look forward to supporting their continued growth and helping them achieve their vision for a more sustainable future.”

Minus Waste Solutions operates a processing facility in Vaughan, Ontario, serving a growing list of commercial, industrial, and institutional clients. With a focus on innovation, the company provides customized programs that divert organic waste from landfill, turning it into animal feed, renewable energy, and other value-added products.

About Minus Waste Solutions
Minus Waste Solutions is a Canadian leader in food waste recycling and resource recovery. Through innovative processes and a commitment to sustainability, the company helps businesses reduce their environmental footprint and create value from food waste streams.

About Canada Business Growth Fund (CBGF)
The Canadian Business Growth Fund (CBGF) provides long-term, patient, minority capital to ambitious entrepreneurs to fund the growth and expansion of mid-market businesses with investments between $5 and $20 million. An evergreen investment fund with capital commitments of $545 million, CBGF is committed to long-term partnerships with the companies it invests in. As part of its mission to drive growth, CBGF connects business leaders and sector experts to help its partner businesses achieve their full potential.

Website: www.minussolutions.com

SOURCE Minus Waste Solutions

PHOENIX, July 9, 2025 — Trinity Capital Inc. (NASDAQ: TRIN) (“Trinity Capital”), a leading alternative asset manager, today announced the commitment of $35 million in growth capital to INSHUR, a leader in innovative insurance solutions for the on-demand economy.

Operating globally, INSHUR provides commercial insurance for on-demand mobility drivers, fleet operators, and delivery platforms across the mobility and delivery sectors. The company recently surpassed 1 million policies sold in the U.K., one of its core markets. Its platform offers a personalized suite of tech-enabled insurance products, providing flexible coverage and protection that adapts to the distinct needs of on-demand drivers.

“INSHUR understands the unique challenges of drivers across the on-demand economy and is delivering tailored insurance solutions designed to specifically meet those needs,” said Jack McNamara, Director of Tech Lending at Trinity Capital. “We are excited to partner with their team as they continue to scale operations and deliver accessible coverage to drivers around the world.”

This capital will help grow INSHUR’s continued expansion across the U.S., advance its research into AI technologies for underwriting and real-time pricing, develop new solutions for the autonomous vehicle market, and expand partnerships with platforms offering on-demand services.

“With a consistent >50% CAGR since 2023, rapid international growth and a clear path to profitability, this raise helps INSHUR continue to cement its position as the leader in insurance solutions for the on-demand economy. Trinity Capital’s support will enable us to accelerate our U.S. and global expansion, and to leverage our deep insurance and technology expertise to further develop our service offering into innovative and upcoming areas such as autonomous vehicles,” said Dan Bratshpis, CEO and Co-founder of INSHUR.

Burch & Company, Inc., member FINRA/SIPC, through their registered investment banking agent associated with Edge OMC, served as a sole advisor to INSHUR in connection with the transaction.

About Trinity Capital Inc.
Trinity Capital Inc. (NASDAQ: TRIN) is an international alternative asset manager that seeks to deliver consistent returns for investors through access to private credit markets. Trinity Capital sources and structures investments in well-capitalized growth-oriented companies. With five distinct business verticals–Sponsor Finance, Equipment Finance, Tech Lending, Asset-Based Lending, and Life Sciences–Trinity Capital stands as a long-term trusted partner for innovative companies seeking tailored debt solutions. Headquartered in Phoenix, Arizona, Trinity Capital’s dedicated team is strategically located across the United States and in London (UK). For more information on Trinity Capital, please visit trinitycapital.com and stay connected to the latest activity via LinkedIn and X (@trincapital).

About INSHUR
Multi award-winning INSHUR is the fastest-growing global leader in insurance solutions for the on-demand economy, making coverage fair and accessible for drivers and supporting the world’s biggest platform and insurance partners.

Founded in 2016 and with offices in US, UK and Netherlands, INSHUR provides embedded insurance solutions and complementary technology integrations for digital platform providers such as Uber and Amazon. Thanks to its unrivaled underwriting capabilities and exceptional claims handling, INSHUR offers a personalized suite of products that protects the wellbeing of on demand livery and delivery drivers, providing flexible coverage and protection which adapts to the job – helping them stay on the road and keep earning.

As an Uber preferred driver insurance provider in certain European and North American markets, INSHUR is constantly adding to its growing list of platform partners who recognize and value INSHUR for its seamless integration abilities and smooth customer onboarding and relationship management. https://inshurgroup.com/

About Edge OMC
Edge OMC is a boutique investment bank that helps technology and lower mid-market companies raise $20–$250 million in growth capital. Acting as a “Capital Markets-as-a-Service” partner, Edge manages the full capital raise process, allowing CEOs and CFOs to focus on scaling their businesses. With deep expertise in capital markets and company-building, Edge delivers tailored advisory solutions that drive long-term value.

Certain Principals of Edge OMC are licensed investment banking agents, offering securities related services through Burch & Company, Inc., 4151 North Mulberry Drive, Suite 235, Kansas City, MO 64116, member FINRA SIPC.  Burch and Edge OMC are unaffiliated entities.

SOURCE Trinity Capital Inc.

Phoenix-based startup’s proprietary “Flavor-First” technology preserves taste while reducing alcohol content

PHOENIX, July 9, 2025 — ALTR, a pioneering beverage technology company, today announced the successful completion of a $5 million seed funding round to commercialize its groundbreaking alcohol removal technology. The company’s proprietary “Flavor-First” process enables the creation of premium low-alcohol drinks that maintain the full sensory experience.

Backed by leading investors in the beverage and technology sectors, French investment fund Demeter led the round, with participation from Suntory Global Spirits, Techmind, AZ Venture Capital Inc., FTW Ventures, Bluestein Ventures, Solvable, and Xinomavro. The funding will accelerate product development and expand ALTR’s partnerships with some of the world’s best wineries as consumer demand for mindful drinking options continues to surge.

Technology That Preserves What Matters Most

With its proprietary Flavor-First alcohol removal technology, ALTR has cracked the code. Developed specifically for the compounds and structure of alcoholic beverages and engineered for precision ethanol removal at a molecular level, ALTR’s method is non-destructive and non-intrusive—preserving the full sensory experience: flavor, structure, and mouthfeel. Starting with the wine industry, this breakthrough allows the creation of truly premium low-alcohol offerings that honor the craftsmanship of traditional winemaking.

“ALTR is on a quest to remove the stigma of less alcohol for both the consumer and the beverage maker, pairing cutting-edge technology with craft traditions,” said Richard Schatzberger, ALTR’s Founder and CEO.

Science Meets Craftsmanship

ALTR’s team combines world-leading membrane scientists with renowned winemakers to ensure both technical precision and sensory excellence. The company’s low-environmental-impact process aligns with growing sustainability demands in the beverage industry.

Through deep collaborations with wineries, strategic industry partnerships, and a strong commitment to brand-led consumer education, ALTR is setting the standard for what comes next.

“We don’t make ‘de-alcoholized wine’—we just make great wine, it’s that simple,” said Schatzberger. This philosophy is why the technology is now in the hands of some of the most famous winemakers alongside innovative new brands.

Addressing Industry Transformation

This is not a passing trend—it is a necessary transformation. As the wine industry grapples with changing demographics, evolving consumption patterns, and the impact of climate change driving alcohol levels higher, ALTR is leading the charge. By proving that innovation and tradition can coexist, ALTR is paving the way for a more balanced future in wine.

Advanced Science for Amazing Times

This innovation is designed to foster deeper human connection by preserving the social rituals of drinking while reducing the negative impacts of the alcohol molecule.

“We are ushering in the Next Era of Wine,” said Schatzberger. “An era where quality, choice, and well-being are no longer at odds—but finally in harmony.”

Media Contact:

Taylor Foxman

609-432-2237

[email protected]

Elisa Calvello

Director of Strategy and Marketing for ALTR

646.508.3715

[email protected]

SOURCE ALTR

• Series A co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital with syndicate including Bioqube Ventures, Surveyor Capital and others
• Led by founder and drug discovery expert Dr. Andreas Goutopoulos, Actithera’s proprietary three-pillar discovery platform is designed to enable prolonged radioligand tumor retention  
• Proceeds will support clinical development of Actithera’s fibroblast activation protein (FAP)-targeting candidate and pipeline expansion

OSLO, Norway and CAMBRIDGE, Mass., July 9, 2025 — Actithera, a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs), today announced the close of an oversubscribed $75.5 million Series A financing round. The financing will support the advancement of Actithera’s lead FAP asset into clinical development in multiple indications, while also enabling the continued development of its proprietary RLT discovery platform and preclinical pipeline.

The round was co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital, with additional participation from Bioqube Ventures, Innovestor’s Life Science Fund, Investinor, Surveyor Capital (a Citadel company), and second founding investor, Arkin Bio Ventures II.

The Company’s discovery platform combines rational drug design with radiochemistry to create novel small molecule radioligands that overcome current limitations in radiopharmaceutical development. Its three-pillar platform includes first-in-class covalent targeting strategies, designed to optimize tumor residence time, while ensuring rapid systemic clearance – improving precision, safety, and efficacy. Two additional proprietary approaches further support compound differentiation and improve tumor residence time and selectivity. This platform was validated through Actithera’s work on FAP, a high-value theranostic target known for being difficult to drug with molecules that maintain prolonged tumor residency. These efforts have resulted in a FAP-directed RLT development candidate with best-in-class potential due to its optimal pharmacokinetic profile and tumor specificity.

Dr. Andreas Goutopoulos, founder and CEO, brings over 25 years of pharmaceutical and biotech industry experience, including a track record of more than a dozen development candidates. His background includes over a decade of discovery leadership at EMD Serono, where he led medicinal chemistry. In his role as Entrepreneur-in-Residence (EIR) at M Ventures, he led the scientific efforts of and supported a number of oncology small molecule biotechs. At Actithera, he is pioneering a chemistry-driven, precision approach to RLTs by integrating novel covalent-targeting chemistries, rational drug design principles and an isotope-agnostic philosophy.

“We set out to bring structure-based and kinetics-driven thinking from small molecule drug design into the world of radiopharmaceuticals,” said Dr. Andreas Goutopoulos. “This oversubscribed Series A, backed by a truly global and experienced investor syndicate, is strong validation of our approach. We engineer our radioconjugates for extended retention within tumors, making them ideally suited for longer-lived radionuclides and ultimately delivering more convenient dosing schedules and enhanced efficacy and safety for patients.“

Karl Naegler, incoming Board member and Partner at Sofinnova Partners, noted: “Actithera is applying Big Pharma discipline to an emerging field with enormous potential. Its radioligand therapies represent a meaningful shift in oncology, with the opportunity to redefine the therapeutic index. We’re excited to support that vision.”

Roger Franklin, incoming Board member and Partner at Hadean Ventures, added: “Actithera stands out as one of the most thoughtfully constructed radiopharma platforms we’ve seen, combining smart molecular design with a deep understanding of tumor biology and clinical need. The team’s work to align pharmacokinetics with therapeutic effect could transform how patients experience and benefit from radioligand therapies.”

Therese Liechtenstein, incoming Board member and Investment Director at 4BIO Capital, added: “We are honored to support Actithera, whose molecules address key challenges in the nascent radioligand therapies space; a large therapeutic window through high tumor retention and low systemic exposure, applied to a lead program that has significant pan-tumor therapeutic potential.”

Hakan Goker, current Chairman of Actithera, and Managing Director at M Ventures, said: “We are excited to see Actithera evolve from the one-person ideation we seeded with Andreas and Arkin to the transatlantic company it has become today. The innovative chemistry platform built and the first-in-class approach on FAP have the potential for a large impact in the RLT field and a significant benefit for patients. We welcome the new investor group and Board members to the company aligned with this bold vision of building the next generation of RLTs.” 

As part of the Series A financing, Roger Franklin, Partner at Hadean Ventures, Karl Naegler, Partner at Sofinnova Partners, Therese Liechtenstein, Investment Director at 4BIO Capital, and Debbie Dumont, Managing Partner at Bioqube Ventures will join the Actithera Board of Directors, including Noga Yerushalmi, Investment Director at M Ventures, who is currently on the Board.

About Actithera
Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr. Andreas Goutopoulos, and seed investors M Ventures, and Arkin Bio Ventures II, Actithera applies various molecular design strategies, including covalent-targeting and an isotope-agnostic philosophy to invent RLTs with significant differentiation and larger therapeutic windows. Headquartered in Oslo, Norway, and Cambridge, Massachusetts, Actithera is committed to advancing a differentiated pipeline addressing critical unmet needs in oncology. Learn more at www.actithera.com and on LinkedIn.

About M Ventures
M Ventures is the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany. From its headquarters in the Netherlands and offices in Germany, USA and Israel, M Ventures invests globally in transformational ideas driven by innovative entrepreneurs. Taking an active role in its portfolio companies, M Ventures teams up with management teams and co-investors to translate scientific discoveries into commercial success. M Ventures focuses on investing along the two extensive investment areas Biotechnology and Technology covering the areas of Healthcare drug development, Life Science tools, Electronics, and Frontier Technology & Sustainability. For more information, visit m-ventures.com

About Hadean Ventures
Hadean Ventures is a European life science fund manager that invests in life science companies across Europe with a particular focus on the Nordic region. Hadean Ventures is managing funds backed by leading European and US-based, private and institutional investors. Hadean Ventures has offices in Oslo and Stockholm and collaborates with world-class academic institutions and start-up hubs across the region.
https://www.hadeanventures.com

About Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage.

Founded in 1972, Sofinnova Partners is a deeply established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners manages over €4 billion in assets. For more information, please visit: sofinnovapartners.com.

About 4BIO Capital
4BIO Capital (“4BIO”) is an international venture capital firm focused on investing in advanced therapies and emerging modalities, to unlock the treatments of the future. 4BIO’s mission is to invest in, support, and grow early-stage companies solving technical bottlenecks that enable next generation therapeutics in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially transformative therapies for all patients. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors with an unrivalled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space. For more information, connect with us on LinkedIn and Twitter @4biocapital and visit www.4biocapital.com.

About Bioqube Ventures
Bioqube Ventures is an early-stage global life sciences investment firm with offices in Belgium and San Diego, CA. We source, finance and develop first-in-class and/or best- in-class therapeutics to treat patients suffering from debilitating diseases. With our product focused investment strategy, we aim to build balanced portfolios spanning company creation, preclinical and early clinical investments.
https://www.bioqubeventures.com/

SOURCE Actithera